EE173 Cost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in Francecost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in France.
Saved in:
| Title: | EE173 Cost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in Francecost-Effectiveness of Risdiplam for Patients with Types 1 - 3 Spinal Muscular Atrophy (SMA) in France. |
|---|---|
| Authors: | Boussahoua, M1 (AUTHOR), Sutherland, CS2 (AUTHOR), Aponte Ribero, V3 (AUTHOR), Enache, R4 (AUTHOR), Le Lay, K4 (AUTHOR), Le Dissez, C4 (AUTHOR), Chevalier, J1 (AUTHOR) |
| Source: | Value in Health. 2022 Suppl, Vol. 25 Issue 12, pS87-S87. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
